Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis
Open accessThe DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.
Abstract
In experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis (MS), loss of the blood-brain barrier (BBB) tight junction (TJ) protein claudin-3 correlates with immune cell infiltration into the CNS and BBB leakiness. Here we show that sealing BBB TJs by ectopic tetracycline-regulated expression of the TJ protein claudin-1 in Tie-2 tTA//TRE-claudin-1 double transgenic C57BL/6 mice had no influence on immune cell trafficking across the BBB during EAE and furthermore did not influence the onset and severity of the first clinical disease episode. However, expression of claudin-1 did significantly reduce BBB leakiness for both blood borne tracers and endogenous plasma proteins specifically around vessels expressing claudin-1. In addition, mice expressing claudin-1 exhibited a reduced disease burden during the chronic phase of EAE as compared to control littermates. Our study identifies BBB TJs as the critical structure regulating BBB permeability but not immune cell trafficking into CNS during EAE, and indicates BBB dysfunction is a potential key event contributing to disease burden in the chronic phase of EAE. Our observations suggest that stabilizing BBB barrier function by therapeutic targeting of TJs may be beneficial in treating MS, especially when anti-inflammatory treatments have failed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · cited 3×
“In addition to claudin-5 and claudin-3, expression of claudin-12 has also been described at the BBB [35].”
BackgroundKebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Claudin-based tight junctions are crucial for the mammalian epidermal barrier
Furuse, M., Hata, M., Furuse, K., Yoshida, Y., Haratake, A., Sugitani, Y., Noda, T., Kubo, A., & Tsukita, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110122 · Cited by 1,512 · cited 1×
“This notion is supported by previous findings demonstrating that claudin-1 seals TJs in skin epithelial and lung endothelial cells [13, 14].”
ResultBlood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E. A., Perrière, N., Charneau, P., Holloway, K., Leveque, M., Tricoire‐Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,330 · cited 1×
“Later studies, however, which specifically excluded cross-reactivity of anti-claudin-1 antibodies with claudin-3 failed to detect any immunostaining for claudin-1 in CNS parenchymal microvessels or in primary mouse or human brain endothelial cells [2, 20, 43, 47].”
BackgroundComplex Phenotype of Mice Lacking Occludin, a Component of Tight Junction Strands
Saitou, M., Furuse, M., Sasaki, H., Schulzke, J.-D., Fromm, M., Takano, H., Noda, T., & Tsukita, S. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4131 · Cited by 1,195 · cited 2×
“Occludin is highly expressed in TJ of the BBB but not in endothelial TJs of non-neuronal tissues [4, 22], while intact BBB TJs can form in the absence of occludin in vivo [38].”
BackgroundTight junctions of the blood–brain barrier
Wolburg, H., & Lippoldt, A. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00200-8 · Cited by 1,183
Furuse, M., Sasaki, H., Fujimoto, K., & Tsukita, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.391 · Cited by 965 · cited 2×
“In contrast to occludin, claudins have been shown to be sufficient to induce TJ strands when transfected into fibroblasts [15].”
BackgroundMorita, K., Sasaki, H., Furuse, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.185 · Cited by 869 · cited 2×
“Upon transfection into fibroblasts claudin-5 induces E-face associated TJs [34], whereas claudin-3, which is specifically expressed in TJ of CNS but not other endothelial cells [44, 47], induces P-face associated TJs [16].”
BackgroundWnt/β-catenin signaling controls development of the blood–brain barrier
Liebner, S., Corada, M., Bangsow, T., Babbage, J., Taddei, A., Czupalla, C. J., Reis, M., Felici, A., Wolburg, H., Fruttiger, M., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806024 · Cited by 860
Structure and function of claudins
Krause, G., Winkler, L., Mueller, S. L., Haseloff, R. F., Piontek, J., & Blasig, I. E. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.10.018 · Cited by 829 · cited 1×
“The claudin family is comprised of 24 members, which form the backbone of TJs by establishing homophilic and heterophilic interactions via their extracellular loops [26].”
Background(2006) · Elsevier eBooks · doi:10.1016/b978-0-443-07271-0.x5001-0 · Cited by 769
Manner of Interaction of Heterogeneous Claudin Species within and between Tight Junction Strands
Furuse, M., Sasaki, H., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.4.891 · Cited by 746 · cited 3×
“Upon transfection into fibroblasts claudin-5 induces E-face associated TJs [34], whereas claudin-3, which is specifically expressed in TJ of CNS but not other endothelial cells [44, 47], induces P-face associated TJs [16].”
BackgroundOccludin as a possible determinant of tight junction permeability in endothelial cells
Hirase, T., Staddon, J. M., Saitou, M., Ando-Akatsuka, Y., Itoh, M., Furuse, M., Fujimoto, K., Tsukita, S., & Rubin, L. L. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.14.1603 · Cited by 646 · cited 2×
“Occludin is highly expressed in TJ of the BBB but not in endothelial TJs of non-neuronal tissues [4, 22], while intact BBB TJs can form in the absence of occludin in vivo [38].”
BackgroundKERMODE, A. G., THOMPSON, A. J., TOFTS, P., MACMANUS, D. G., KENDALL, B. E., KINGSLEY, D. P. E., MOSELEY, I. F., RUDGE, P., & MCDONALD, W. I. (1990) · Brain · doi:10.1093/brain/113.5.1477 · Cited by 578
Daneman, R., Zhou, L., Agalliu, D., Cahoy, J. D., Kaushal, A., & Barres, B. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013741 · Cited by 577 · cited 2×
“Occludin is highly expressed in TJ of the BBB but not in endothelial TJs of non-neuronal tissues [4, 22], while intact BBB TJs can form in the absence of occludin in vivo [38].”
BackgroundClaudins in occluding junctions of humans and flies
Furuse, M., & Tsukita, S. (2006) · Trends in Cell Biology · doi:10.1016/j.tcb.2006.02.006 · Cited by 528 · cited 1×
“The individual claudins display tissue specific expression patterns and differ in their individual properties in forming dynamic aqueous pores that allow size- and charge-selective paracellular diffusion [17].”
BackgroundLiebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E.-H., Kalbacher, H., & Wolburg, H. (2000) · Acta Neuropathologica · doi:10.1007/s004010000180 · Cited by 491 · cited 1×
“Previous studies have shown immunostaining for claudin-1 in brain endothelium [31].”
Occludin: Structure, function and regulation
FELDMAN, G., MULLIN, J., & RYAN, M. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.01.009 · Cited by 485 · cited 1×
“In contrast expression of specific occludin splice variants (summarized in [12] or changes in phosphorylation state may influence BBB TJ function.”
BackgroundWolburg, H., Wolburg-Buchholz, K., Kraus, J., Rascher-Eggstein, G., Liebner, S., Hamm, S., Duffner, F., Grote, E.-H., Risau, W., & Engelhardt, B. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0688-z · Cited by 454 · cited 7×
“We have previously observed the specific loss of claudin-3 immunostaining from those brain microvessels that were surrounded by inflammatory infiltrates [47], suggesting a direct role for inflammatory cells in disrupting BBB TJs.”
BackgroundResultSelf-citationKirk, J., Plumb, J., Mirakhur, M., & McQuaid, S. (2003) · The Journal of Pathology · doi:10.1002/path.1434 · Cited by 375 · cited 3×
“In these studies, abnormal distributions of TJ proteins such as occludin and ZO-1 in brain vessels were found to correlate with enhanced BBB leakiness for serum proteins [25, 37].”
BackgroundWolburg, H., Neuhaus, J., Kniesel, U., Krauß, B., Schmid, E.-M., Öcalan, M., Farrell, C., & Risau, W. (1994) · Journal of Cell Science · doi:10.1242/jcs.107.5.1347 · Cited by 366
Claudin-based barrier in simple and stratified cellular sheets
Tsukita, S., & Furuse, M. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00362-9 · Cited by 363 · cited 1×
“TJ strands or particles are composed of integral transmembrane proteins [16], of which occludin and the claudins have been identified to date [40, 41].”
BackgroundEngelhardt, B., & Wolburg, H. (2004) · European Journal of Immunology · doi:10.1002/eji.200425327 · Cited by 334 · cited 2×
“BBB TJs could be disrupted by the immune cells penetrating the BBB on a paracellular route through the endothelial cell–cell contacts or alternatively, immune cells might traverse the BBB on a transcellular route through the brain endothelial cell itself and thus indirectly alter BBB TJ architecture (summarized in [9]…”
BackgroundSelf-citationStructural and signalling molecules come together at tight junctions
Tsukita, S., Furuse, M., & Itoh, M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00016-2 · Cited by 305 · cited 2×
“TJ strands or particles are composed of integral transmembrane proteins [16], of which occludin and the claudins have been identified to date [40, 41].”
BackgroundComparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis
Lassmann, H. (1983) · Schriftenreihe Neurologie / Neurology Series · doi:10.1007/978-3-642-45558-2 · Cited by 296 · cited 1×
“Increased BBB permeability is a characteristic hallmark of the pathological alterations observed in the CNS in MS and in its animal model EAE [27].”
BackgroundGraesser, D., Solowiej, A., Bruckner, M., Osterweil, E., Juedes, A., Davis, S., Ruddle, N. H., Engelhardt, B., & Madri, J. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213595 · Cited by 273 · cited 1×
“This view is supported by the observation that mice deficient for the cell–cell contact molecule PECAM-1 develop aggravated EAE due to impaired BBB cell–cell contact integrity combined with increased inflammatory cell recruitment across the BBB into the CNS [18].”
BackgroundSelf-citationBennett, J., Basivireddy, J., Kollar, A., Biron, K. E., Reickmann, P., Jefferies, W. A., & McQuaid, S. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.011 · Cited by 265 · cited 2×
“EAE reliably models the inflammatory phase of MS and BBB alterations observed in EAE resemble those observed in MS [1].”
BackgroundPlumb, J., McQuaid, S., Mirakhur, M., & Kirk, J. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00430.x · Cited by 262 · cited 4×
“In these studies, abnormal distributions of TJ proteins such as occludin and ZO-1 in brain vessels were found to correlate with enhanced BBB leakiness for serum proteins [25, 37].”
BackgroundInfluentialGreenwood, J., Heasman, S. J., Alvarez, J. I., Prat, A., Lyck, R., & Engelhardt, B. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2010.01140.x · Cited by 240 · cited 1×
“While much has been learned regarding the sequential steps of immune cell rolling or capture, adhesion and crawling on the BBB, the cellular pathways and the molecular cues mediating immune cell diapedesis across the BBB are only just being unraveled (summarized in [6, 19]).”
BackgroundSelf-citationWolburg, H., Wolburg-Buchholz, K., Liebner, S., & Engelhardt, B. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01927-9 · Cited by 210 · cited 1×
“Confirming our previous observations [48] TJs of the choroid plexus epithelium expressed all molecules analyzed (including claudin-1 and claudin-2) except claudin-5.”
ResultSelf-citationThe pathology of multiple sclerosis
Lucchinetti, C. F., Parisi, J., & Bruck, W. (2005) · Neurologic Clinics · doi:10.1016/j.ncl.2004.09.002 · Cited by 208
Witt, K. A., Mark, K. S., Hom, S., & Davis, T. P. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00589.2003 · Cited by 192 · cited 1×
“Upon transfection into fibroblasts claudin-5 induces E-face associated TJs [34], whereas claudin-3, which is specifically expressed in TJ of CNS but not other endothelial cells [44, 47], induces P-face associated TJs [16].”
BackgroundCoisne, C., Dehouck, L., Faveeuw, C., Delplace, Y., Miller, F., Landry, C., Morissette, C., Fenart, L., Cecchelli, R., Tremblay, P., et al. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700281 · Cited by 183 · cited 1×
“Later studies, however, which specifically excluded cross-reactivity of anti-claudin-1 antibodies with claudin-3 failed to detect any immunostaining for claudin-1 in CNS parenchymal microvessels or in primary mouse or human brain endothelial cells [2, 20, 43, 47].”
BackgroundFujibe, M., Chiba, H., Kojima, T., Soma, T., Wada, T., Yamashita, T., & Sawada, N. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.12.014 · Cited by 164 · cited 1×
“This notion is supported by previous findings demonstrating that claudin-1 seals TJs in skin epithelial and lung endothelial cells [13, 14].”
ResultNatalizumab: Targeting α4-Integrins in Multiple Sclerosis
Engelhardt, B., & Kappos, L. (2008) · Neurodegenerative Diseases · doi:10.1159/000109933 · Cited by 154
Self-citationLyck, R., Ruderisch, N., Moll, A. G., Steiner, O., Cohen, C. D., Engelhardt, B., Makrides, V., & Verrey, F. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.72 · Cited by 140 · cited 1×
“0 Array, Affymetrix UK, High Wycombe, UK) was performed exactly as described before [32].”
MethodSelf-citationHamm, S., Dehouck, B., Kraus, J., Wolburg‐Buchholz, K., Wolburg, H., Risau, W., Cecchelli, R., Engelhardt, B., & Dehouck, M. (2004) · Cell and Tissue Research · doi:10.1007/s00441-003-0825-y · Cited by 138 · cited 1×
“Later studies, however, which specifically excluded cross-reactivity of anti-claudin-1 antibodies with claudin-3 failed to detect any immunostaining for claudin-1 in CNS parenchymal microvessels or in primary mouse or human brain endothelial cells [2, 20, 43, 47].”
BackgroundSelf-citationLeech, S., Kirk, J., Plumb, J., & McQuaid, S. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00781.x · Cited by 137 · cited 3×
“Immunohistological analysis of post mortem brain samples of MS patients has identified BBB TJs as the anatomical route for BBB leakiness in MS [29].”
BackgroundHerrero-Herranz, E., Pardo, L. A., Gold, R., & Linker, R. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.01.001 · Cited by 124 · cited 1×
“As the degree of demyelination and/or axonal damage have been described as morphological correlates to increasing disability in MS and clinical severity of EAE [21], we undertook an effort to determine if ameliorated chronic EAE in Tie-2//TRE-claudin-1 C57BL/6 double transgenic mice was due to reduced CNS pathology.”
BackgroundExperimental models of multiple sclerosis
Lassmann, H. (2007) · Revue Neurologique · doi:10.1016/s0035-3787(07)90474-9 · Cited by 121
Morgan, L., Shah, B., Rivers, L. E., Barden, L., Groom, A. J., Chung, R., Higazi, D., Desmond, H., Smith, T., & Staddon, J. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.04.051 · Cited by 118 · cited 1×
“ported by the observation of occludin dephosphorylation in spinal cord microvessels in a rat model of EAE corresponding with the onset of CNS inflammation [33].”
BackgroundFabis, M. J., Scott, G. S., Kean, R. B., Koprowski, H., & Hooper, D. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701252104 · Cited by 99 · cited 1×
“Similarly, in EAE, loss of BBB integrity has been recognized as a fundamental event in pathogenesis and further the magnitude of BBB dysfunction has been correlated with disease severity [11].”
BackgroundInduction of Blood Brain Barrier Tight Junction Protein Alterations by CD8 T Cells
Suidan, G. L., Mcdole, J. R., Chen, Y., Pirko, I., & Johnson, A. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003037 · Cited by 95 · cited 1×
“In addition, CD8 T cells were shown to initiate BBB TJ disruption in vivo through a non-apoptotic perforin-dependent mechanism [39].”
BackgroundPadden, M., Leech, S., Craig, B., Kirk, J., Brankin, B., & McQuaid, S. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0145-x · Cited by 80 · cited 1×
“In these studies, evaluation of a large number of brain vessels by immunofluorescence staining and semi-quantitative thick-section confocal analysis demonstrated TJ abnormalities manifested by beading, interruption or absence of junctional immunostaining or appearance of diffuse cytoplasmic staining for the TJ protein…”
BackgroundEngelhardt, B. (2010) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2010.009.x · Cited by 78 · cited 1×
“While much has been learned regarding the sequential steps of immune cell rolling or capture, adhesion and crawling on the BBB, the cellular pathways and the molecular cues mediating immune cell diapedesis across the BBB are only just being unraveled (summarized in [6, 19]).”
BackgroundSelf-citationEngelhardt, B., Kempe, B., Merfeld-Clauss, S., Laschinger, M., Furie, B., Wild, M. K., & Vestweber, D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.1267 · Cited by 73 · cited 2×
“5 = limp tail, 1 = hind leg paraparesis, 2 = hind leg paraplegia, and 3 = hind leg paraplegia with incontinence [8].”
BackgroundMethodSelf-citationInducible endothelial cell-specific gene expression in transgenic mouse embryos and adult mice
Deutsch, U., Schlaeger, T. M., Dehouck, B., Döring, A., Tauber, S., Risau, W., & Engelhardt, B. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.12.026 · Cited by 28 · cited 4×
“Inducibility of claudin-1 expression in responder lines was tested by mating TRE-claudin-1 mice with Tie-2 tTA activator mice expressing tTA in an endothelial cell-specific manner to generate double transgenic mice [5].”
BackgroundMethodSelf-citationMcQuaid, S., Plumb, J., Mirakhur, M., & Kirk, J. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.39286_15.x · Cited by 27
Uboldi, C., Döring, A., Alt, C., Estess, P., Siegelman, M. H., & Engelhardt, B. (2008) · European Journal of Immunology · doi:10.1002/eji.200838209 · Cited by 22 · cited 1×
“In vitro antigen-recall assays were carried out with MOGaa35–55-immunized single, and double transgenic Tie2 tTA//TRE–claudin-1 mice, as described before [42].”
MethodSelf-citationThe Blood-Brain Barrier in EAE
Engelhardt, B., & Wolburg, H. (2008) · Springer eBooks · doi:10.1007/0-387-25518-4_20 · Cited by 2
Self-citationKanda, T. (2010) · Clinical and Experimental Neuroimmunology · doi:10.1111/j.1759-1961.2009.00005.x · Cited by 2
Cited by
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Capture, crawl, cross: the T cell code to breach the blood–brain barriers
Engelhardt, B., & Ransohoff, R. M. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.07.004 · Cited by 686
Self-citationBrain barriers: Crosstalk between complex tight junctions and adherens junctions
Tietz, S., & Engelhardt, B. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201412147 · Cited by 551
“Using the EAE model, a critical function for BBB TJs in maintaining barrier functions of the BBB in neuroinflammation has been further supported by the observation that inducible endothelial cell–specific ectopic expression of claudin-1 ameliorated clinical symptoms of EAE in mice by specifically blocking BBB leakines…”
BackgroundInfluentialSelf-citationJunctional proteins of the blood-brain barrier: New insights into function and dysfunction
Stamatovic, S. M., Johnson, A. M., Keep, R. F., & Andjelkovic, A. V. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1154641 · Cited by 428
“Some other claudins, like claudin-1 and ¡12, are considered to be inducible in brain endothelial cells.(14) Claudin-1 shares a common 3D-structure with claudin-3 and 5, which involves a b-sheet comprising both extracellular segments anchored to a transmembranous 4-helix bundle.”
Background
Metadata
- Authors
- Pfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B.
- Affiliations
- University of Bern (CH)
- University of Zurich (CH)
- University Hospital of Basel (CH)
- Corresponding author
- Engelhardt, Britta
- Venue
- Acta Neuropathologica
- Published
- 2011-10-09
- Volume
- 122
- Issue
- 5
- Pages
- 601-614
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC3207130
- OpenAlex
- W2045454822
- Cited by
- 160
- References
- 54
- Citations by year
- 2026: 2 · 2025: 17 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 8 · 2020: 12 · 2019: 9 · 2018: 11 · 2017: 15 · 2016: 12 · 2015: 11 · 2014: 15 · 2013: 11 · 2012: 12
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- reroDoc Digital Library (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc)
- Open Access CRIS of the University of Bern
- Funders
- European Commission (202213, 241861, 201024)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- claudin-1, blood-brain barrier, tight junctions, experimental autoimmune encephalomyelitis, multiple sclerosis, blood-brain barrier permeability, immune cell trafficking, claudin-3, tetracycline-regulated gene expression, plasma protein leakage
- MeSH terms
- Animals, Blood-Brain Barrier, Cell Movement, Central Nervous System, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Endothelium, Vascular, Gene Expression Regulation, Membrane Proteins, Mice, Inbred C57BL, Mice, Transgenic, Multiple Sclerosis, Tetracycline, Tight Junctions, Receptor, TIE-2, Mice, Claudin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.